Early detection of anthracycline‐ and trastuzumab‐induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters

Early detection of anthracycline‐ and trastuzumab‐induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters

Abstract Aims To evaluate echocardiographic and biomarker changes during chemotherapy, assess their ability to early detect and predict cardiotoxicity and to define the best time for their evaluation. Methods and results Seventy‐two women with breast cancer (52 ± 9.8 years) treated with anthracyclin...

Full description

Bibliographic Details
Main Authors: Belén Díaz‐Antón, Rodrigo Madurga, Blanca Zorita, Samantha Wasniewski, Andrea Moreno‐Arciniegas, Beatriz López‐Melgar, Natalia Ramírez Merino, Roberto Martín‐Asenjo, Patricia Barrio, Maximiliano German Amado Escañuela, Jorge Solís, Francisco Javier Parra Jiménez, Eva Ciruelos, José María Castellano, Leticia Fernández‐Friera
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:ESC Heart Failure
Subjects:
Cardiotoxicity
Anthracyclines
Trastuzumab
High‐sensitivity cardiac troponin
Global longitudinal strain
Online Access:https://doi.org/10.1002/ehf2.13782

Internet

https://doi.org/10.1002/ehf2.13782

Similar Items